Health / Medical Topics

    Yttrium Y 90-DOTA-Biotin

    Pronunciation

    Definition 1

    A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) with radioimmunotherapy property. Biotin is a water-soluble B-complex vitamin, present in minute amounts in every living cell, while its level in cancerous tissue is higher than that of normal tissue. Y 90-DOTA-Biotin could be used in 3-step pre-targeting radioimmunotherapy that employs a tumor targeting antibody conjugated with streptavidin, the natural ligand of biotin. (NCI Thesaurus)

    Definition 2

    A compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to the chemical streptavidin. Yttrium Y 90 DOTA-biotin will find tumor cells in the body that have been targeted by an antibody linked to streptavidin and kill them. It is being studied together with CC49-streptavidin in the treatment of cancer. (NCI Dictionary)




    YOU MAY ALSO LIKE

    A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that…
    A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can bind to tumor cells that…
    A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
    A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-clivatuzumab tetraxetan contains a monoclonal antibody that binds to…
    A substance being studied in the treatment of some types of cancer. Yttrium Y 90 SMT 487 contains a molecule that binds…
    An injectable formulation of the radioisotope yttrium Y 90 encapsulated in resin microspheres with potential antineoplastic activity. When injected into arterial vasculature…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact